[15] For licensed GLP-1 receptor agonists, the Yellow Card scheme has contributed to the pharmacovigilance process that informed the EMA PRAC 2024 review and MHRA communications on psychiatric safety signals across this drug class
The CBP lysine acetyltransferase is a well-recognized, direct NRF2 binding partner (Tonelli et al, 2018), contributing to NRF2 transcriptional activity at reporter genes (Katoh et al, 2001) and responsible for acetylating NRF2 itself (Sun et al, 2009)
Clinical trials show that most patients report symptom improvement by week 8 without medication changes
Why Does Wegovy Cause Changes in the Buttocks
urged national regulators to strengthen pharmacovigilance for GLP-1s, including routine collection of misuse cases, adverse outcomes and hospitalisations in the context of eating disorders 19
Telehealth psychiatry is often covered in states with parity laws